Leaflet CORETON HCT 80mg / 12.5mg film-coated tablets


Indicated for: hypertension

Route of administration: oral

Substance: valsartan + hydrochlorothiazide (angiotensin II receptor blocker + diuretic)

ATC: C09CA03 (Cardiovascular system | Angiotensin II receptor blockers (arbs), plain | Angiotensin ii receptor blockers (arbs), plain)

Precautions:
Dose adjustment in renal impairment
Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Photosensitivity
Photosensitivity

Avoid excessive exposure to sunlight or UV radiation.

Hypotension / fall risk
Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances
Electrolyte disturbances

This medicine may change blood electrolyte levels.

The combination of valsartan and hydrochlorothiazide is used for the treatment of hypertension, particularly in patients who do not respond adequately to monotherapy. Valsartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels and lowers blood pressure by blocking the effects of angiotensin II. Hydrochlorothiazide is a thiazide diuretic that helps eliminate excess salt and water from the body, thereby reducing blood pressure.

This combination is administered orally, usually once daily, and the dosage is adjusted based on the patient's response and blood pressure levels. It is important for patients to adhere to the treatment and regularly monitor their blood pressure.

Common side effects include dizziness, headaches, fatigue, and hypokalemia. In rare cases, severe adverse reactions such as renal failure, hyponatremia, or allergic reactions may occur.

The combination of valsartan and hydrochlorothiazide provides an effective option for managing hypertension, helping to reduce the risk of cardiovascular complications such as myocardial infarction or stroke.

General data about CORETON HCT 80mg / 12.5mg

  • Substance: valsartan + hydrochlorothiazide
  • Date of last drug list: 01-07-2013
  • Commercial code: W54981001
  • Concentration: 80mg / 12.5mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 28
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Concentrations available for valsartan + hydrochlorothiazide

  • 160mg/12.5mg
  • 160mg/25mg
  • 320mg/12.5mg
  • 320mg/25mg
  • 80mg/12.5mg

Combinations with other substances